business
CEO Sells 34K Shares of Biotech Stock, Valued at $615,000, According to Latest SEC Filing
Key takeaways
- NVCR Frank Leonard, Chief Executive Officer of Novo Cure Limited (NASDAQ:NVCR), reported an open-market sale of 34,273 common shares for a transaction value of ~$615,000 on June 4, 2026, according to a SEC Form 4 filing.
- Post-transaction value (direct ownership)
- Transaction value based on SEC Form 4 reported price ($17.93); post-transaction value based on June 4, 2026, market close ($17.99).
NVCR Frank Leonard, Chief Executive Officer of Novo Cure Limited (NASDAQ:NVCR), reported an open-market sale of 34,273 common shares for a transaction value of ~$615,000 on June 4, 2026, according to a SEC Form 4 filing.
Post-transaction value (direct ownership)
Transaction value based on SEC Form 4 reported price ($17.93); post-transaction value based on June 4, 2026, market close ($17.99).
Article preview — originally published by Yahoo Finance. Full story at the source.
Read full story on Yahoo Finance →
More top stories
Also covered by
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop